Prescribing Information (the drug label): what it means on a GLP-1

By the GLP-1 SOS Editorial Team

·

A glowing green hologram of an open book with interface pages and molecule outlines above a small glass magnifier on a white surface

Definition

The Prescribing Information, or drug label, is the FDA-approved document that sets out a medicine’s uses, doses, warnings and side effects. It is the reference the GLP-1 Lab checks its numbers against.

The FDA describes prescription drug labeling as a summary of the essential scientific information needed to use a drug safely and effectively. It includes the Prescribing Information and FDA-approved patient labeling, such as the Medication Guide. A GLP-1 label opens with Highlights and a boxed warning, then numbered sections: indications (section 1), dosage (2), contraindications (4), warnings and precautions (5), adverse reactions (6), drug interactions (7), clinical pharmacology (12) and clinical studies (14). Each label shows a revision date; the current Wegovy label is revised June 2026.

Two tips help when reading one. Adverse reaction tables compare the drug with placebo, so the gap matters: nausea in 44% of adults on Wegovy 2.4 mg vs 16% on placebo means many people feel nausea either way, but more do on the drug. The postmarketing section lists reports collected after approval; the labels note their frequency cannot be reliably estimated. You can find current labels on DailyMed from the National Library of Medicine.

At GLP-1 SOS every number in the Lab is checked against the current labels, and when a label does not say something, we say so.

In the Lab

GLP-1 SOS

From the people behind the Lab

You do not have to figure this out alone.

GLP-1 SOS is the daily companion made for life on a GLP-1. Plain answers like this one, a support team that replies to real questions from real people, and daily formulas like GLP-1 SOS Daily Gut Relief, designed around the side effects that come with the medication. The GLP-1 Lab is our free education arm: no login, no paywall, no hype. Side effects are part of the road. Suffering through them is not.

Sources (3)

Reviewed by the GLP-1 SOS editorial team · Education, not medical advice · Talk to your prescriber about your dose and your symptoms.

GLP-1 SOS

Written by

GLP-1 SOS Editorial Team

Discover more from The GLP-1 Lab

Subscribe now to keep reading and get access to the full archive.

Continue reading